Find Research Outputs

Search results

• Article

  ¹⁸F-DOPA and¹⁸F-FDG PET/CT, scintigraphic localization and radioguided surgery of recurrent medullary thyroid cancer: Two case reports

  Evangelista, L., Farsad, M., Piotto, A. & Pelizzo, M. R., Oct 1 2014, In: Current Radiopharmaceuticals. 7, 2, p. 133-137 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Medullary Thyroid cancer
  • Positron-Emission Tomography
  • Radiopharmaceuticals
  • Nuclear Medicine
  • Recurrence

• 18F-DOPA and other radiopharmaceuticals for imaging unknown primary neuroendocrine tumors

  Schillaci, O., Mar 1 2014, In: Journal of Nuclear Medicine. 55, 3, p. 357-359 3 p.

  Research output: Contribution to journal › Article › peer-review

• 18F-DOPA PET/CT and MRI Findings in a Patient With Multiple Meningiomas

  Calabria, F. F., Chiaravalloti, A., Calabria, E. N., Grillea, G. & Schillaci, O., May 13 2016, (Accepted/In press) In: Clinical Nuclear Medicine.

  Research output: Contribution to journal › Article › peer-review

  • Meningioma
  • Tremor
  • Brain
  • Upper Extremity
  • Headache

• 18F-DOPA PET/CT for assessment of response to induction chemotherapy in a child with high-risk neuroblastoma

  Piccardo, A., Lopci, E., Foppiani, L., Morana, G. & Conte, M., 2014, In: Pediatric Radiology. 44, 3, p. 355-361 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Induction Chemotherapy
  • Neuroblastoma
  • 3-Iodobenzylguanidine
  • Child
  • Radiopharmaceuticals

• ¹⁸F-DOPA PET/CT in neuroblastoma: Comparison of conventional imaging with CT/MR

  Lopci, E., Piccardo, A., Nanni, C., Altrinetti, V., Garaventa, A., Pession, A., Cistaro, A., Chiti, A., Villavecchia, G. & Fanti, S., Apr 2012, In: Clinical Nuclear Medicine. 37, 4

  Research output: Contribution to journal › Article › peer-review

  • Neuroblastoma
  • Sensitivity and Specificity
  • 3-Iodobenzylguanidine
  • Positron Emission Tomography Computed Tomography
  • Biopsy

• 18F-DOPA PET/CT in the evaluation of hereditary SDH-deficiency paraganglioma-pheochromocytoma syndromes

  Marzola, M. C., Chondrogiannis, S., Grassetto, G., Rampin, L., Maffione, A. M., Ferretti, A., Opocher, G., Schiavi, F., Colletti, P. M. & Rubello, D., Jan 2014, In: Clinical Nuclear Medicine. 39, 1

  Research output: Contribution to journal › Article › peer-review

  • Paraganglioma
  • Succinate Dehydrogenase
  • Pheochromocytoma
  • Mutation
  • Positron Emission Tomography Computed Tomography

• 18F-DOPA PET/CT Physiological Distribution and Pitfalls: Experience in 215 Patients

  Calabria, F. F., Chiaravalloti, A., Jaffrain-Rea, M. L., Zinzi, M., Sannino, P., Minniti, G., Rubello, D. & Schillaci, O., Jul 23 2016, (Accepted/In press) In: Clinical Nuclear Medicine.

  Research output: Contribution to journal › Article › peer-review

  • Exocrine Glands
  • Brain Neoplasms
  • Endocrine Glands
  • Whole Body Imaging
  • Neuroendocrine Tumors

• ¹⁸F-DOPA Positron Emission Tomography in Medulloblastoma: 2 Case Reports

  Cicone, F., Clerico, A., Minniti, G., Paiano, M., Carideo, L., Scaringi, C., Langen, K. J. & Scopinaro, F., Sep 1 2016, In: World Neurosurgery. 93, p. 490 1 p.

  Research output: Contribution to journal › Article › peer-review

  • Medulloblastoma
  • fluorodopa F 18
  • Positron-Emission Tomography
  • Amino Acids
  • Natural History

• 18F-DOPA uptake does not correlate with IDH mutation status and 1p/19q co-deletion in glioma

  Cicone, F., Carideo, L., Scaringi, C., Arcella, A., Giangaspero, F., Scopinaro, F. & Minniti, G., Apr 2019, In: Annals of Nuclear Medicine. 33, 4, p. 295-302 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Glioma
  • Positron-Emission Tomography
  • Mutation
  • Survival
  • Dermatoglyphics

• 18F-DOPA Uptake of Developmental Venous Anomalies in Children With Brain Tumors

  Morana, G., Piccardo, A., Garrè, M. L., Cabria, M. & Rossi, A., Feb 24 2016, (Accepted/In press) In: Clinical Nuclear Medicine.

  Research output: Contribution to journal › Article › peer-review

  • Brain Neoplasms
  • Dihydroxyphenylalanine
  • Child
  • Blood Vessels
  • Nuclear Medicine

• ¹⁸F-FCH and ⁹⁰Y PET/CT data for the early evaluation of HCC radioembolisation

  Ferrari, C., Di Palo, A., Niccoli Asabella, A., Didonna, V., Ranieri, G., Gadaleta, C. D. & Rubini, G., Oct 1 2018, In: Clinical and Translational Imaging. 6, 5, p. 357-367 11 p.

  Research output: Contribution to journal › Article › peer-review

  • fluorocholine
  • fluoromethylcholine
  • Microspheres
  • Positron-Emission Tomography
  • Physiologic Monitoring

• 18F-FDG and 68Ga-somatostatin analogs PET/CT in patients with Merkel cell carcinoma: a comparison study

  Taralli, S., Sollini, M., Milella, M., Perotti, G., Filice, A., Menga, M., Versari, A. & Rufini, V., Jul 21 2018, In: EJNMMI Research. 8, 1, p. 64

  Research output: Contribution to journal › Article › peer-review

  • Merkel Cell Carcinoma
  • Somatostatin
  • Glucose
  • Somatostatin Receptors
  • Neuroendocrine Tumors

• ¹⁸F-FDG and ⁶⁸Ga-somatostatin analogs PET/CT in patients with Merkel cell carcinoma: a comparison study

  Taralli, S., Sollini, M., Milella, M., Perotti, G., Filice, A., Menga, M., Versari, A. & Rufini, V., Jan 1 2018, In: EJNMMI Research. 8, 64.

  Research output: Contribution to journal › Article › peer-review

  • Merkel Cell Carcinoma
  • Somatostatin
  • Glucose
  • Somatostatin Receptors
  • Neuroendocrine Tumors

• ¹⁸F-FDG and amyloid PET imaging in Alzheimer's disease

  Chiaravalloti, A. & Schillaci, O., 2012, In: Journal of Alzheimer's Disease. 29, SUPPL. 1, p. 13-15 3 p.

  Research output: Contribution to journal › Article › peer-review

• ¹⁸F-FDG in the differential diagnosis of neurodegenerative dementias

  Del Sole, A., Redaelli, V., Caroppo, P. & Priori, A., Dec 1 2019, In: Clinical and Translational Imaging. 7, 6, p. 437-445 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Fluorodeoxyglucose F18
  • Dementia
  • Cognitive Dysfunction
  • Differential Diagnosis
  • Primary Progressive Aphasia

• 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma

  Fonti, R., Salvatore, B., Quarantelli, M., Sirignano, C., Segreto, S., Petruzziello, F., Catalano, L., Liuzzi, R., Rotoli, B., Del Vecchio, S., Pace, L. & Salvatore, M., Feb 1 2008, In: Journal of Nuclear Medicine. 49, 2, p. 195-200 6 p.

  Research output: Contribution to journal › Article › peer-review

  • technetium 99m methoxyisobutylisonitrile
  • Fluorodeoxyglucose F18
  • Multiple Myeloma
  • Pelvis
  • Spine

• ¹⁸F-FDG PET/CT, ^99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: A comparative study

  Fonti, R., Pace, L., Cerchione, C., Catalano, L., Salvatore, B., De Luca, S., Pane, F., Salvatore, M. & Del Vecchio, S., Apr 21 2015, In: Clinical Nuclear Medicine. 40, 4, p. 303-308 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Fluorodeoxyglucose F18
  • Multiple Myeloma
  • Progression-Free Survival
  • Survival
  • Bone Marrow

• ¹⁸F-FDG PET/CT and urothelial carcinoma: Impact on management and prognosis—a multicenter retrospective study

  Zattoni, F., Incerti, E., Dal Moro, F., Moschini, M., Castellucci, P., Panareo, S., Picchio, M., Fallanca, F., Briganti, A., Gallina, A., Fanti, S., Schiavina, R., Brunocilla, E., Rambaldi, I., Lowe, V., Karnes, J. R. & Evangelista, L., May 2019, In: Cancers. 11, 5, 700.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Fluorodeoxyglucose F18
  • Multicenter Studies
  • Urinary Bladder Neoplasms
  • Retrospective Studies
  • Carcinoma

• 18F-FDG PET/CT and Urothelial Carcinoma: Impact on Management and Prognosis-A Multicenter Retrospective Study

  Zattoni, F., Incerti, E., Dal Moro, F., Moschini, M., Castellucci, P., Panareo, S., Picchio, M., Fallanca, F., Briganti, A., Gallina, A., Fanti, S., Schiavina, R., Brunocilla, E., Rambaldi, I., Lowe, V., Karnes, J. R. & Evangelista, L., May 20 2019, In: Cancers. 11, 5, p. 1-14 14 p.

  Research output: Contribution to journal › Article › peer-review

  • Fluorodeoxyglucose F18
  • Multicenter Studies
  • Urinary Bladder Neoplasms
  • Retrospective Studies
  • Carcinoma

• 18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer

  Crivellaro, C., Signorelli, M., Guerra, L., De Ponti, E., Buda, A., Dolci, C., Pirovano, C., Todde, S., Fruscio, R. & Messa, C., Oct 2012, In: Gynecologic Oncology. 127, 1, p. 131-135 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Fluorodeoxyglucose F18
  • Uterine Cervical Neoplasms
  • Glycolysis
  • Tumor Burden
  • Neoplasm Metastasis

• ¹⁸F-FDG PET/CT en un angiomixoma agresivo de la pelvis

  Gilardi, L., Vadrucci, M., Pittaro, A., Pennacchioli, E. & Rizzo, S., Nov 1 2017, In: Revista Espanola de Medicina Nuclear e Imagen Molecular. 36, 6, p. 403-405 3 p.

  Research output: Contribution to journal › Article › peer-review

• ¹⁸F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer

  De Giorgi, U., Mego, M., Rohren, E. M., Liu, P., Handy, B. C., Reuben, J. M., Macapinlac, H. A., Hortobagyi, G. N., Cristofanilli, M. & Ueno, N. T., Aug 2010, In: Journal of Nuclear Medicine. 51, 8, p. 1213-1218 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Circulating Neoplastic Cells
  • Fluorodeoxyglucose F18
  • Cell Count
  • Breast Neoplasms
  • Neoplasm Metastasis

• 18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease

  Zamagni, E., Nanni, C., Gay, F., Pezzi, A., Patriarca, F., Bellò, M., Rambaldi, I., Tacchetti, P., Hillengass, J., Gamberi, B., Pantani, L., Magarotto, V., Versari, A., Offidani, M., Zannetti, B., Carobolante, F., Balma, M., Musto, P., Rensi, M., Mancuso, K. & 10 others, Dimitrakopoulou-Strauss, A., Chauviè, S., Rocchi, S., Fard, N., Marzocchi, G., Storto, G., Ghedini, P., Palumbo, A., Fanti, S. & Cavo, M., Feb 1 2016, In: Leukemia. 30, 2, p. 417-422 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Smoldering Multiple Myeloma
  • Fluorodeoxyglucose F18
  • Positron-Emission Tomography
  • Osteolysis
  • Positron Emission Tomography Computed Tomography

• 18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease

  Zamagni, E., Nanni, C., Gay, F., Pezzi, A., Patriarca, F., Bellò, M., Rambaldi, I., Tacchetti, P., Hillengass, J., Gamberi, B., Pantani, L., Magarotto, V., Versari, A., Offidani, M., Zannetti, B. A., Carobolante, F., Balma, M., Musto, P., Rensi, M., Mancuso, K. & 10 others, Dimitrakopoulou-Strauss, A., Chauvie, S., Rocchi, S., Fard, N., Marzocchi, G., Storto, G., Ghedini, P., Palumbo, A., Fanti, S. & Cavo, M., Feb 1 2016, In: Leukemia. 30, 2, p. 417-422 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Smoldering Multiple Myeloma
  • Fluorodeoxyglucose F18
  • Positron-Emission Tomography
  • Osteolysis
  • Positron Emission Tomography Computed Tomography

• ¹⁸F-FDG PET/CT for Early Postradiotherapy Assessment in Solitary Bone Plasmacytomas

  Alongi, P., Zanoni, L., Incerti, E., Fallanca, F., Mapelli, P., Papathanasiou, N., Gianolli, L., Picchio, M. & Bomanji, J., Aug 30 2015, In: Clinical Nuclear Medicine. 40, 8, p. e399-e404

  Research output: Contribution to journal › Article › peer-review

  • Plasmacytoma
  • Fluorodeoxyglucose F18
  • Bone and Bones
  • Progression-Free Survival
  • Radiotherapy

• ¹⁸F-FDG PET/CT for early prediction of response to neoadjuvant lapatinib, trastuzumab, and their combination in HER2-positive breast cancer: Results from neo-ALTTO

  Gebhart, G., Gámez, C., Holmes, E., Robles, J., Garcia, C., Cortés, M., De Azambuja, E., Fauria, K., Van Dooren, V., Aktan, G., Coccia-Portugal, M. A., Kim, S. B., Vuylsteke, P., Cure, H., Eidtmann, H., Baselga, J., Piccart, M., Flamen, P. & Di Cosimo, S., Nov 1 2013, In: Journal of Nuclear Medicine. 54, 11, p. 1862-1868 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Lapatinib
  • human ERBB2 protein
  • Trastuzumab
  • Fluorodeoxyglucose F18
  • Breast Neoplasms

• ¹⁸F-FDG PET/CT for response assessment in Hodgkin lymphoma undergoing immunotherapy with checkpoint inhibitors

  Castello, A., Grizzi, F., Qehajaj, D., Rahal, D., Lutman, R. & Lopci, E., Jan 1 2018, (Accepted/In press) In: Leukemia and Lymphoma.

  Research output: Contribution to journal › Article › peer-review

  • Fluorodeoxyglucose F18
  • Hodgkin Disease
  • Immunotherapy
  • Tumor Burden
  • pembrolizumab

• 18F-FDG PET/CT impact on testicular tumours clinical management

  Ambrosini, V., Zucchini, G., Nicolini, S., Berselli, A., Nanni, C., Allegri, V., Martoni, A., Domenico, R., Cricca, A. & Fanti, S., Apr 2014, In: European Journal of Nuclear Medicine and Molecular Imaging. 41, 4, p. 668-673 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Testicular Neoplasms
  • Fluorodeoxyglucose F18
  • Positron Emission Tomography Computed Tomography
  • Seminoma
  • Sensitivity and Specificity

• 18F-FDG PET/CT in gastric MALT lymphoma: a bicentric experience

  Albano, D., Bertoli, M., Ferro, P., Fallanca, F., Gianolli, L., Picchio, M., Giubbini, R. & Bertagna, F., 2017, In: European Journal of Nuclear Medicine and Molecular Imaging. 44, 4, p. 589-597 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Familial primary gastric lymphoma
  • Marginal Zone B-Cell Lymphoma
  • Fluorodeoxyglucose F18
  • Pylorus
  • Gastritis

• 18F-FDG PET/CT in Labrune Syndrome

  Cuzzocrea, M., Florimonte, L., Scola, E., Benti, R. & Castellani, M., Oct 1 2020, In: Clinical Nuclear Medicine. 45, 10, p. e439-e440

  Research output: Contribution to journal › Article › peer-review

  • Leukoencephalopathy Brain Calcifications and Cysts
  • Fluorodeoxyglucose F18
  • Leukoencephalopathies
  • Functional Neuroimaging
  • Genetic Testing

• 18F-FDG-PET/CT in malignant mesothelioma

  Fuccio, C., Spinapolice, E. G., Ferretti, A., Castellucci, P., Marzola, M. C., Trifirò, G. & Rubello, D., Jul 2013, In: Biomedicine and Pharmacotherapy. 67, 6, p. 539-542 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Malignant Mesothelioma
  • Fluorodeoxyglucose F18
  • Mesothelioma
  • Molecular Imaging
  • PubMed

• 18F-FDG PET/CT in Metastatic Pilomatrix Carcinoma

  Vadrucci, M., Gilardi, L., Crivelli, F., Baroli, A. & Lomuscio, G., Dec 2016, In: Clinical Nuclear Medicine. 41, 12, p. e525-e526

  Research output: Contribution to journal › Article › peer-review

  • Fluorodeoxyglucose F18
  • Carcinoma
  • Positron Emission Tomography Computed Tomography
  • Scalp
  • Neoplasm Metastasis

• 18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapy

  Evangelista, L., Cuppari, L., Menis, J., Bonanno, L., Reccia, P., Frega, S. & Pasello, G., Aug 2019, In: Nuclear Medicine Communications. 40, 8, p. 802-807 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Fluorodeoxyglucose F18
  • Non-Small Cell Lung Carcinoma
  • Immunotherapy
  • Tomography
  • Biomarkers

• ¹⁸F-FDG PET/CT in the evaluation of cartilaginous bone neoplasms: the added value of tumor grading

  Annovazzi, A., Anelli, V., Zoccali, C., Rumi, N., Persichetti, A., Novello, M., Sciuto, R., Bertoni, F., Ferraresi, V. & Biagini, R., Nov 1 2019, In: Annals of Nuclear Medicine. 33, 11, p. 813-821 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Chondrosarcoma
  • Bone Neoplasms
  • Neoplasm Grading
  • Fluorodeoxyglucose F18
  • Sensitivity and Specificity

• 18F-FDG PET/CT in the evaluation of recurrent ovarian cancer: A prospective study on forty-one patients

  Nanni, C., Rubello, D., Farsad, M., De Iaco, P., Sansovini, M., Erba, P., Rampin, L., Mariani, G. & Fanti, S., Sep 2005, In: European Journal of Surgical Oncology. 31, 7, p. 792-797 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Fluorodeoxyglucose F18
  • Ovarian Neoplasms
  • Tomography
  • Prospective Studies
  • Radio

• ¹⁸F-FDG PET/CT in therapy response and in predicting responders or non-responders in malignant pleural mesothelioma patients, by using semi-quantitative mRECIST and EORTC criteria

  Asabella, A. N., Di Palo, A., Altini, C., Fanelli, M., Ferrari, C., Lavelli, V., Ranieri, G., Gadaleta, C. D. & Rubini, G., Sep 1 2018, In: Hellenic Journal of Nuclear Medicine. 21, 3, p. 191-197 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Malignant Mesothelioma
  • Fluorodeoxyglucose F18
  • Neoplasms
  • Positron Emission Tomography Computed Tomography
  • Area Under Curve

• 18F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival to Preoperative Radiochemotherapy with Bevacizumab in High Risk Locally Advanced Rectal Cancer

  Avallone, A., Aloj, L., Pecori, B., Caraco, C., De Stefano, A., Tatangelo, F., Silvestro, L., Granata, V., Bianco, F., Romano, C., Di Gennaro, F., Budillon, A., Petrillo, A., Muto, P., Botti, G., Delrio, P. & Lastoria, S., 2019, In: Journal of Nuclear Medicine.

  Research output: Contribution to journal › Article › peer-review

  • Bevacizumab
  • Chemoradiotherapy
  • Fluorodeoxyglucose F18
  • Rectal Neoplasms
  • Survival

• ¹⁸F-FDG PET/CT ist ein prognostischer biomarker bei patienten mit für brustkrebspatientinnen mit knochenmetastasen im vergleich zu¹⁸F-NaFPET/CT

  Piccardo, A., Puntoni, M., Morbelli, S., Massollo, M., Bongioanni, F., Paparo, F., Altrinetti, V., Gonella, R., Gennari, A., Iacozzi, M., Sambuceti, G. & DeCensi, A., 2015, In: Nuklearmedizin. 54, 4, p. 163-172 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Fluorodeoxyglucose F18
  • Biomarkers
  • Breast Neoplasms
  • Neoplasm Metastasis
  • Bone and Bones

• 18F-FDG PET/CT scans for children and adolescents

  Lassmann, M., Eberlein, U., Tosi, G. & Chiti, A., 2014, In: The Lancet Oncology. 15, 7

  Research output: Contribution to journal › Article › peer-review

• ¹⁸F-FDG PET/CT versus bone scintigraphy in the follow-up of gastric cancer

  Sollini, M., Calabrese, L., Zangheri, B., Erba, P. A., Gramaglia, A. & Gasparini, M., Mar 1 2016, In: Revista Espanola de Medicina Nuclear e Imagen Molecular. 35, 2, p. 121-123 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Fluorodeoxyglucose F18
  • Radionuclide Imaging
  • Stomach Neoplasms
  • Thoracic Vertebrae
  • Bone and Bones

• ¹⁸F-FDG PET/MR in herpes simplex virus encephalitis: A case study

  Schillaci, O., Chiaravalloti, A., Chiaravalloti, A., Travascio, L., Floris, R. & Simonetti, G., 2014, In: Revista Espanola de Medicina Nuclear e Imagen Molecular. 33, 4, p. 249-250 2 p.

  Research output: Contribution to journal › Article › peer-review

• ¹⁸F-FDG PET-derived parameters as prognostic indices in hepatic malignancies after ⁹⁰Y radioembolization: is there a role?

  Bagni, O., Filippi, L. & Schillaci, O., 2014, In: European Journal of Nuclear Medicine and Molecular Imaging. 42, 3, p. 367-369 3 p.

  Research output: Contribution to journal › Article › peer-review

• 18F–FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer’s disease (AD) patients at the mild cognitive impairment (MCI) stage

  Morbelli, S., Bauckneht, M., Arnaldi, D., Picco, A., Pardini, M., Brugnolo, A., Buschiazzo, A., Pagani, M., Girtler, N., Nieri, A., Chincarini, A., De Carli, F., Sambuceti, G. & Nobili, F., Nov 1 2017, In: European Journal of Nuclear Medicine and Molecular Imaging. 44, 12, p. 2073-2083 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Cognitive Dysfunction
  • Alzheimer Disease
  • Dementia
  • Temporal Lobe
  • Kaplan-Meier Estimate

• 18F-FDG PET Identifies Altered Brain Metabolism in Patients with Cri du Chat Syndrome

  Cistaro, A., Quartuccio, N., Piccardo, A., Fania, P., Spunton, M., Liava, A., Danesino, C., Albani, G. & Guala, A., Aug 1 2020, In: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 61, 8, p. 1195-1199 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Cri-du-Chat Syndrome
  • Fluorodeoxyglucose F18
  • Phenotype
  • Brain
  • Limbic Lobe

• ¹⁸F-FDG PET in pediatric lymphomas: A comparison with conventional imaging

  Lopci, E., Burnelli, R., Ambrosini, V., Nanni, C., Castellucci, P., Biassoni, L., Rubello, D. & Fanti, S., Dec 1 2008, In: Cancer Biotherapy and Radiopharmaceuticals. 23, 6, p. 681-689 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Fluorodeoxyglucose F18
  • Positron-Emission Tomography
  • Lymphoma
  • Pediatrics
  • Hodgkin Disease

• 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer

  Cascini, G. L., Avallone, A., Delrio, P., Guida, C., Tatangelo, F., Marone, P., Aloj, L., De Martinis, F., Comella, P., Parisi, V. & Lastoria, S., Aug 1 2006, In: Journal of Nuclear Medicine. 47, 8, p. 1241-1248 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Chemoradiotherapy
  • Fluorodeoxyglucose F18
  • Rectal Neoplasms
  • Neoplasms
  • raltitrexed

• ¹⁸F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu's arteritis

  Incerti, E., Tombetti, E., Fallanca, F., Baldissera, EM., Alongi, P., Tombolini, E., Sartorelli, S., Sabbadini, MG., Papa, M., De Cobelli, F., Mason, JC., Gianolli, L., Manfredi, AA. & Picchio, M., 2017, In: European Journal of Nuclear Medicine and Molecular Imaging. 44, 7, p. 1109-1118 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Takayasu Arteritis
  • Fluorodeoxyglucose F18
  • Transplants
  • Inflammation

• 18F-FDG PET-TC con doppio tempo di acquisizione nella identificazione delle lesioni mammarie

  Caprio, M. G., Cangiano, A., Imbriaco, M., Soscia, F., Di Martino, G., Farina, A., Avitabile, G., Pace, L., Forestieri, P. & Salvatore, M., Mar 2010, In: Radiologia Medica. 115, 2, p. 215-224 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Fluorodeoxyglucose F18
  • Breast
  • Prone Position
  • Positron Emission Tomography Computed Tomography
  • Sensitivity and Specificity

• 18F-FDG PET uptake in the pre-Huntington disease caudate affects the time-to-onset independently of CAG expansion size

  Ciarmiello, A., Giovacchini, G., Orobello, S., Bruselli, L., Elifani, F. & Squitieri, F., Jun 2012, In: European Journal of Nuclear Medicine and Molecular Imaging. 39, 6, p. 1030-1036 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Huntington Disease
  • Fluorodeoxyglucose F18
  • Glucose
  • Positron-Emission Tomography
  • Basal Metabolism

• 18F-FDG positron autoradiography with a particle counting silicon pixel detector

  Russo, P., Lauria, A., Mettivier, G., Montesi, M. C., Marotta, M., Aloj, L. & Lastoria, S., Nov 7 2008, In: Physics in Medicine and Biology. 53, 21, p. 6227-6243 17 p.

  Research output: Contribution to journal › Article › peer-review

  • Silicon
  • Fluorodeoxyglucose F18
  • Autoradiography
  • Electrons
  • Noise